about
Influence of Size and Shape on the Anatomical Distribution of Endotoxin-Free Gold Nanoparticles.Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle.Longitudinal tracking of triple labeled umbilical cord derived mesenchymal stromal cells in a mouse model of Amyotrophic Lateral Sclerosis.Internalization of nanopolymeric tracers does not alter characteristics of placental cells.Fate of PLA and PCL-Based Polymeric Nanocarriers in Cellular and Animal Models of Triple-Negative Breast Cancer.Organ Distribution and Bone Tropism of Cellulose Nanocrystals in Living Mice.Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia.Bioreducible Hydrophobin-Stabilized Supraparticles for Selective Intracellular Release.Correction: Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscleMultiple intracerebroventricular injections of human umbilical cord mesenchymal stem cells delay motor neurons loss but not disease progression of SOD1G93A mice.Single particle extinction and scattering optical method unveils in real time the influence of the blood components on polymeric nanoparticles.Biocompatible Polymer Nanoformulation To Improve the Release and Safety of a Drug Mimic Molecule Detectable via ICP-MS.Protection of Brain Injury by Amniotic Mesenchymal Stromal Cell-Secreted Metabolites.Evolution of Nanoparticle Protein Corona across the Blood-Brain BarrierRepeated administration of the food additive E171 to mice results in accumulation in intestine and liver and promotes an inflammatory statusDexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine Model
P50
Q30101052-6D03DD69-8D2A-4974-98D5-0A318A6935C8Q35550169-749D24BA-AC89-431C-8674-95D64482D676Q35692674-D6D78675-97AC-40FC-B0E2-45B99663CFD7Q36942333-D689FE3E-2733-4228-B146-C71E78AFC5DCQ38801249-745344C7-8EBF-458E-9D82-8B7A3381936CQ38979481-25951082-23DF-4221-85B2-798C4685EFE2Q39745261-19986679-7F4A-4F4D-8560-3D28CD56C7D0Q41662449-378E9898-14F9-4FB0-9C63-093AF33C55E3Q42363674-1AE87326-56B6-4877-97FC-4428D6187E3AQ47333614-2A38422E-DF8B-4075-A353-F27C95616917Q48013056-A835019F-812C-41C7-A0EE-5D09C4E5ED18Q48166930-22F6A39E-9CD3-4160-BB18-909238F9118DQ48475882-01A0D5BA-F685-4E7F-9B82-EBE83D50860DQ89311521-15D46727-EB47-48A6-AAEA-826FA7EC417AQ91602772-2119A1C6-8072-4F97-947F-A12BD9B2FD3BQ92440235-7969DFB9-3414-45C8-B448-0427321E2570
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-6010-2947
@en
name
Laura Talamini
@ast
Laura Talamini
@en
Laura Talamini
@es
Laura Talamini
@nl
type
label
Laura Talamini
@ast
Laura Talamini
@en
Laura Talamini
@es
Laura Talamini
@nl
prefLabel
Laura Talamini
@ast
Laura Talamini
@en
Laura Talamini
@es
Laura Talamini
@nl
P106
P1153
56525113500
P21
P31
P496
0000-0001-6010-2947